Publication
No evidence that GATA3 rs570613 SNP modifies breast cancer risk
Sharon E. Johnatty, Fergus J. Couch, Zachary Fredericksen, Robert Tarrell, Amanda B. Spurdle, Jonathan Beesley, Xiaoqing Chen, Daphne Gschwantler-Kaulich, Christian F. Singer, Christine Fuerhauser, Anneliese Fink-Retter, Susan M. Domchek, Katherine L. Nathanson, Vernon S. Pankratz, Noralane M. Lindor, Andrew K. Godwin, Maria A. Caligo, John Hopper, Melissa C. Southey, Graham G. Giles, Christina Justenhoven, Hiltrud Brauch, Ute Hamann, Yon-Dschun Ko, Tuomas Heikkinen, Kirsimari Aaltonen, Kristiina Aittomäki, Carl Blomqvist, Heli Nevanlinna, Per Hall, Kamila Czene, Jianjun Liu, Susan Peock, Margaret Cook, Radka Platte, D. Gareth Evans, Fiona Lalloo, Rosalind Eeles, Gabriella Pichert, Diana Eccles, Rosemarie Davidson, Trevor Cole, Jackie Cook, Fiona Douglas, Carol Chu, Shirley Hodgson, Joan Paterson, Frans B. L. Hogervorst, Matti A. Rookus, Caroline Seynaeve, Juul Wijnen, Maaike Vreeswijk, Marjolijn Ligtenberg, Rob B. van der Luijt, Theo A. M. van Os, Hans J. P. Gille, Marinus J. Blok, Claudine Issacs, Manjeet K. Humphreys, Lesley McGuffog, Sue Healey, Olga Sinilnikova, Antonis C. Antoniou, Douglas F. Easton, Georgia Chenevix-Trench
Breast Cancer Research and Treatment, December 2008, Springer Science + Business Media
DOI: 10.1007/s10549-008-0257-1